Liviniti, a national PBM leader in transparency and prescription drug savings, announces a new collaboration with Mindera Health to improve management of moderate-to-severe psoriasis patients. The program utilizes Mind.Px™, a dermal biomarker patch, to improve clinical outcomes while reducing biologic drug costs for self-funded employers.
Liviniti is proud to announce that LeAnn Boyd, CEO, is part of the prestigious group of 20 healthcare leaders selected to receive the MM+M 2024 Pinnacle Awards. Honorees include leaders, marketers, strategists and creators who have scaled healthcare industry heights, with years of high achievement ahead of them. Pinnacle Awards honorees will be profiled in the May print edition of MM+M and celebrated at an in-person event scheduled for May 2 in New York City.
LeAnn Boyd, Liviniti CEO, is slated to speak at the National Association of Benefits and Insurance Professionals (NABIP) Capitol Conference on February 27. Held at the Washington, D.C. Hyatt Regency on Capitol Hill, the 34th annual conference highlights healthcare issues that affect the health insurance industry and impact the roles of agents and brokers.
Long recognized as a PBM leader in transparency and prescription drug savings, Liviniti is excited to announce the addition of the Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to its network of pharmacies.
Liviniti, a pharmacy benefit manager (PBM) committed to transparent pricing, announced today that it is partnering with Noom’s enterprise unit, Noom for Work, to assist U.S. employers in the complex arena of weight management.